Data / Form D filings / Otolith Sound, Inc.
Otolith Sound, Inc.: Form D filings
Otolith Sound, Inc., a biotechnology company in Washington, DC, filed 5 Form D notices with the SEC between 2016 and 2024. The latest, on October 9, 2024, reports $4.9 million sold of a $8.9 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 MASSACHUSETTS AVE NW, FL7, Washington, DC, 20001
- Phone
- (571) 263-3498
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1677664
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 9, 2024 | New notice | $8,917,717 | $4,899,055 | $4,018,662 | 3 | Jul 29, 2024 | sec.gov |
| Feb 7, 2023 | New notice | $24,799,853 | $24,799,853 | 33 | Jan 23, 2023 | sec.gov | |
| Nov 28, 2018 | New notice | $750,000 | $750,000 | 11 | Oct 26, 2018 | sec.gov | |
| Apr 13, 2018 | New notice | $500,000 | $405,000 | $95,000 | 4 | Apr 10, 2018 | sec.gov |
| Jun 21, 2016 | New notice | $250,000 | $25,000 | $225,000 | 1 | Jun 10, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Tom Hardart | Executive Officer | |
| Samuel Owen | Executive Officer, Director | |
| Kevin Franck | Executive Officer | |
| Jon Akers | Executive Officer | |
| Didier Depireux | Executive Officer | |
| Dan Wagner | Executive Officer | |
| Anthony Aiudi | Director | |
| Raphael Michel | Director |
Other biotechnology companies in District of Columbia that filed recently
- OptoVista Holdings, LLC $3.7 million · Sep 25, 2026
Every Form D from the week of Oct 7, 2024 · All recent filings in District of Columbia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Otolith Sound, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.